Healthcare
Hospitals/Medical Services
from 288 today
We value the company at 18x EV/EBITDA on FY28E and maintain our BUY rating with a target price of INR 350, supported by sustained long-term growth from its 10,000-bed expansion vision, cluster-based strategy, and improving patient mix.
Ratings and target prices as published by each firm. Each summary condenses that firm's stated view in its own note and is attributed to it; no report text is reproduced.
